| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Contents
|
|
|
2012
|
104 |
1 |
p. CO4-
1 p.
|
artikel
|
| 2 |
Differences in external price referencing in Europe—A descriptive overview
|
Leopold, Christine
|
|
2012
|
104 |
1 |
p. 50-60
11 p.
|
artikel
|
| 3 |
Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries
|
Hoebert, Joëlle M.
|
|
2012
|
104 |
1 |
p. 76-83
8 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2012
|
104 |
1 |
p. ii-
1 p.
|
artikel
|
| 5 |
Evaluation on the first 2 years of the positive list system in South Korea
|
Park, Sung Eun
|
|
2012
|
104 |
1 |
p. 32-39
8 p.
|
artikel
|
| 6 |
From evidence assessments to coverage decisions? The case example of glinides in Germany
|
Kreis, Julia
|
|
2012
|
104 |
1 |
p. 27-31
5 p.
|
artikel
|
| 7 |
Geographic variation in health care – 40 years of “small-area variation”
|
|
|
2012
|
104 |
1 |
p. I-
1 p.
|
artikel
|
| 8 |
How innovative are pharmaceutical innovations? The case of medicines financed through add-on payments outside of the French DRG-based hospital payment system
|
Gridchyna, Inna
|
|
2012
|
104 |
1 |
p. 69-75
7 p.
|
artikel
|
| 9 |
Regulatory agencies, pharmaceutical information and the Internet: A European perspective
|
Bauschke, Rafael
|
|
2012
|
104 |
1 |
p. 12-18
7 p.
|
artikel
|
| 10 |
Scanning the horizon—Development and implementation of an early awareness system for anticancer drugs in Austria
|
Nachtnebel, Anna
|
|
2012
|
104 |
1 |
p. 1-11
11 p.
|
artikel
|
| 11 |
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
|
Daw, Jamie R.
|
|
2012
|
104 |
1 |
p. 19-26
8 p.
|
artikel
|
| 12 |
The effects of new pricing and copayment schemes for pharmaceuticals in South Korea
|
Lee, Iyn-Hyang
|
|
2012
|
104 |
1 |
p. 40-49
10 p.
|
artikel
|
| 13 |
Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists
|
Quintal, Carlota
|
|
2012
|
104 |
1 |
p. 61-68
8 p.
|
artikel
|
| 14 |
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden
|
Pettersson, Billie
|
|
2012
|
104 |
1 |
p. 84-91
8 p.
|
artikel
|
| 15 |
When health technologies do not reach their effectiveness potential: A health service research perspective
|
Campillo-Artero, Carlos
|
|
2012
|
104 |
1 |
p. 92-98
7 p.
|
artikel
|
Tijdschrift beschrijving